ArticleMolecular pharmacology2019

Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin-Induced CYP3A4 and MDR1 Gene Expression.

Kodye L Abbott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.